Bilateral hearing loss during vincristine therapy: A case report

Kalcioglu M., Kuku I., KAYA E., Oncel S., Aydogdu I.

JOURNAL OF CHEMOTHERAPY, cilt.15, sa.3, ss.290-292, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 3
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1179/joc.2003.15.3.290
  • Dergi Adı: JOURNAL OF CHEMOTHERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.290-292
  • Anahtar Kelimeler: vincristine, hearing loss, toxicity, peripheral T-cell lymphoma, OTOTOXICITY
  • İnönü Üniversitesi Adresli: Evet

Özet

Vincristine sulfate is a chemotherapeutic agent used in different cancer therapies. It is also the first choice of treatment for peripheral T-cell lymphoma with cyclophosphamide and adriamycin. Sudden hearing loss during vincristine therapy is a very rare event. This is a case of a 16-year old girl who developed sudden bilateral hearing loss related to vincristine therapy.